Effectiveness, Safety of Zetia and Vytorin, Cholesterol Drugs, in Doubt

Zetia and Vytorin are two widely prescribed cholesterol drugs. Both drug are marketed and sold by Schering-Plough and Merck.

Cardiologists have been demanding Schering-Plough and Merck come forward with clinical trials to prove the drugs’ effectiveness and safety. Cardiologists fear that if the drugs prove to be less effective than advertised, patients may be putting themselves at unnecessary risk of heart attacks. Approximately 800,000 Americans are prescribed Zetia and Vytorin each year.

So far neither Schering-Plough nor Merck have published the results of Zetia and Vytorin trials. This ain’t Denmark, but something’s rotten here.

And this also ain’t Kansas, so the wizards at Schering-Plough and Merck better publish the data, if it’s true. 800,000 live depend on it!

Alex Berenson, The New York Times 11/21/2007 Read Article: The New York Times

Trade Secrets Used To Block Disclosure Of Safety Concern

It’s hard to imagine anything standing in the way of the public’s right to know when a corporation endangers the health and safety of a community. Yet, it happens every day under the guise of protecting a corporation’s “trade secret.”

Here’s a case in point.

California officials refuse to disclose the ingredients of a chemical pesticide sprayed over fields, homes, businesses and schools in Northern California. California say it can’t identify the “inactive ingredients” of the pesticide without violating laws “governing corporate trade secrets.”

Spraying of the pesticide was suspended after residents complained that the initial application caused asthma-like symptoms, burning eyes, rashes and stomach pains. This problem raises a basic question: How can any corporation have a right keep a safety hazard a secret? Read -- Paul Pringle, LA Times 10/18/2007 Read Article: LA Times

Drug Maker to Block Sale of Low Cost Cancer Drug

The good and bad of money…money…. money!

Pharmaceutical giant Genetech makes Avastin, a cancer drug that is also used to treat macular degeneration, which causes blindness in the elderly. Genetech also makes Lucentis, a drug used to treat macular degeneration. And, that’s good!

But, here’s the problem: Retinal specialists prefer to use Avastin because of its cheaper, about $50 a dose, while Lucentis costs about $2000 a dose. And, that’s good!

If it keeps making Avastin, Genetech will lose $1950 per dose. So, Genetech has told retinal specialists that it not going to produce Avastin, because Lucentis is “really-really-no-joke-pinky-swear” better than Avastin. And, that’s bad!

Elderly folks can’t afford a drug that cost $2000 a dose to prevent blindness, so they’ll go blind. And, that’s bad!

Andrew Pollack, The New York Times 10/12/2007 Read Article: The New York Times

Child Cough Medicines Recalled

Johnson & Johnson has ordered a voluntary recall of certain cough and cold products for infants amid reports that misuse could lead to overdoses.

A Johnson & Johnson spokesman says the recall affects infants under two years of age who are particularly at risk for overdose if the products were not administered properly.

The products being recalled include: infants' Tylenol Drops Plus Cold; Concentrated Infants' Tylenol Drops Plus Cold & Cough; Pediacare Infant Drops Decongestant; Pediacare Infant Drops Decongestant & Cough; Pediacare Infant Dropper Decongestant; Pediacare Infant Dropper Long-Acting Cough; and Pediacare Infant Dropper Decongestant & Cough (PE) products.

The Food and Drug Administration issued a public health advisory earlier this year warning parents not give cough and cold medicines to infants and toddlers without a doctor’s direction.

AP, The Washington Post 10/11/2007 Read Article: The Washington Post

Class Action Against Microsoft, Best Buy to Proceed

They got caught! They got caught!

The Supreme Court, conservative bent notwithstanding, upheld a ruling Monday that will allow a class action lawsuit against Microsoft Corp. and Best Buy Co. to go forward.

The federal class action lawsuit involves thousands of consumers, just like you and me, that were cheated when Microsoft Corp. and Best Buy Co. surreptitiously charged them for services they did not want.

Microsoft Corp. and Best Buy Co. had asked the Supremes to dismiss the lawsuit which alleges violation of racketeering laws.

AP, LA Times 10/16/2007 Read Article: LA Times

Legality of Donelon's Insurance Program Questioned

Corporate Welfare: The House Insurance Committee grilled state and insurance officials over whether a proposed grant of $100 million in state funds can legally be given to insurance companies. The plan, announced by Gov. Blanco and Insurance Commissioner Jim Donelon, would provide up to $100 million in matching grants to insurers that would write new homeowners' business in Louisiana. Ed Anderson, New Orleans Times-Picayune 04/19/2007 Read Article: New Orleans Times-Picayune